Purchase Order 75N93021P00506

The National Institutes of Health's National Center for Advancing Translational Sciences (NCATS) awarded a $285,899 firm-fixed price purchase order to Government Scientific Source Inc. to upgrade an existing Opera Phenix Plus high content screening system. The upgrades include a Robot LiveCell system, environmental control unit, liquid handling system, and 40X water objective to enhance capabilities such as environmental control, liquid handling, live imaging, robotic plate handling, image...

Specs Chemical Services, Inc. was awarded a $900,000 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to deliver a curated collection of over 6,000 screening compounds based on the Broad Institute Repurposing Set. The compounds will support the Center's drug discovery efforts by enabling screening and identification of potential drug candidates. As requested in the solicitation, Specs Chemical Services will provide the...

This firm fixed-price purchase order for $30,778.40 was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Discoverx Products, LLC. The contract is to provide one PathHunter detection kit (PN 93-0001XL) to support NCATS' high-throughput screening efforts for GPR151, a target related to pain and addiction under the NIH HEAL (Helping to End Addiction Long-term) Initiative. Eurofins Discoverx Products was...

This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $208,187.00 contract provides an annual service agreement for Molecular Devices' FLIPR Tetra high-throughput cellular screening systems, which are used in NCATS' research on GPCR, ion channel, and stem cell projects with implications for pain and opioid...

This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Promega Corporation, a global life sciences company, to provide P450-Glo screening systems including CYP26A1, CYP26B1, and CYP3A4 assay kits. The $123,592.50 contract supports the Tox21 collaboration between NCATS, the National Toxicology Program, EPA, and FDA, which aims to screen thousands of compounds in vitro to develop better toxicity...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed price purchase order to Revvity Health Sciences, Inc. for the purchase of two reagent kits: the HTRF cAMP Gi Assay kit and the HTRF cAMP Gs Dynamic Assay kit. The total potential value of the award is $243,665.00. These kits will be used by NCATS' Tox21 group to screen a library of 10,000 compounds as part of a cross-partner project...

This contract was awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Promega Corporation, a for-profit manufacturer of laboratory equipment, reagents, and consumables. The $113,836.25 firm fixed-price purchase order is for the delivery of Promega's Caspase-Glo 3/7 Assay and CellTiter-Glo One Solution Assay, which are used in cell-based assays to test the apoptosis detection and cytotoxicity of siRNA libraries. The contract does not utilize a set-aside...

This purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to BMG Labtech, Inc. is for the delivery of two high-throughput screening multimodal microplate readers. The solicitation requested quotations for readers able to perform fluorescence, luminescence, absorbance, and time-resolved fluorescence assays in an automated fashion when integrated with existing NIH robotic platforms. Valued at $324,474.75, the firm fixed price contract...

The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $55,800 firm-fixed-price purchase order contract to Promega Corporation for the supply of P450-Glo CYP26A1 and CYP26B1 Screening Systems. This non-competitive contract, awarded without set-aside, will provide NCATS with specialized laboratory equipment and reagents to support its biomedical research and testing programs. Promega, a global life sciences company, is a...

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $3.86 million firm fixed price purchase order to Molecular Devices LLC for the acquisition of five Molecular Devices ImageXpress Confocal High-Content Imaging Systems, one FLIPR Penta high-throughput cellular screening system, along with associated software, services, consumables, installation, training, customization, maintenance, and technical support. The products and services are to support the...